Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.473
Buy
RSI(14)
58.681
Neutral
STOCH(KDJ)(9,3,3)
15.108
Oversold
ATR(14)
3.779
High Vlolatility
CCI(14)
-15.482
Neutral
Williams %R
69.833
Sell
TRIX(12,20)
2.660
Sell
StochRSI(14)
95.825
Buy
Search
EUDA Health Holdings Ltd
EUDAAdd to Watchlist
14.380USD
+0.030+0.21%
Close 05/13, 16:00（ET）Quotes delayed by 15 min
35.87MMarket Cap
LossP/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of EUDA Health Holdings Ltd
Currency: USD Updated: 2026-05-13Key Insights
EUDA Health Holdings Ltd's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 132 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very low.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 55.00.In the medium term, the stock price is expected to trend down.Despite strong stock market performance and technicals over the past month, the fundamentals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
EUDA Health Holdings Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
EUDA Health Holdings Ltd Highlights
StrengthsRisks
EUDA Health Holdings Limited is a health technology company. The Company operates a southeast Asian digital healthcare ecosystem. Its unified artificial intelligence platform assesses patients' medical history, triages conditions, digitally connects patients with clinicians, and predicts optimal treatment outcomes. Its holistic approach supports patients throughout all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions, and aftercare services. Its medical urgent care services provide healthcare assistance and medical evacuation to individual and corporate clients. Its property management service covers the management of properties, such as condominiums and shopping malls. Its services include e-triage, GP consult, e-medical certificates, and medical prescriptions. Its EUDA platform provides medical services from primary to post-surgery care and ongoing preventive healthcare for clients, regardless of the level of healthcare required.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 84.01% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 6.82M.
Undervalued
The company’s latest PE is -9.69, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 2.32K shares, decreasing 89.90% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 0.00 shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 1.43.
Analyst Rating
Based on
1
analysts
Buy
Current Rating
55.000
Target Price
+281.94%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-05-13The current financial score of EUDA Health Holdings Ltd is 4.15, ranking 206 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 104.28K, representing a year-over-year decrease of 95.71%, while its net profit experienced a year-over-year decrease of 227.87%.
Score
Financials
6.59
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
4.41
Operational Efficiency
0.00
Growth Potential
4.75
Shareholder Returns
5.00
EUDA Health Holdings Ltd's Company Valuation
Currency: USD Updated: 2026-05-13The current valuation score of EUDA Health Holdings Ltd is 7.44, ranking 85 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -9.69, which is -936.48% below the recent high of 81.02 and -1402.69% above the recent low of -145.55.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 132/206
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-05-13The current earnings forecast score of EUDA Health Holdings Ltd is 8.00, ranking 66 out of 206 in the Healthcare Equipment & Supplies industry. The average price target is 6.00, with a high of 6.00 and a low of 6.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
1
analysts
Buy
Current Rating
55.000
Target Price
+281.94%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
93
Total
4
Median
7
Average
Company name
Ratings
Analysts
EUDA Health Holdings Ltd
EUDA
1
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
34
Veeva Systems Inc
VEEV
33
Thermo Fisher Scientific Inc
TMO
31
1
2
3
...
19
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-05-13The current price momentum score of EUDA Health Holdings Ltd is 7.54, ranking 45 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 24.97 and the support level at 4.53, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
14.066
Buy
MA10
14.671
Sell
MA20
11.850
Buy
MA50
10.470
Buy
MA100
20.967
Sell
MA200
34.836
Sell
Institutional Confidence
Currency: USD Updated: 2026-05-13The current institutional shareholding score of EUDA Health Holdings Ltd is 3.00, ranking 133 out of 206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 0.09%, representing a quarter-over-quarter decrease of 96.33%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.00% of shares outstanding, with 1.00% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Risk Assessment
Currency: USD Updated: 2026-05-13The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of EUDA Health Holdings Ltd is 1.17, ranking 192 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.55. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.
Score
Beta vs S&P 500 index
0.55
VaR
--
240-Day Maximum Drawdown
+93.24%
240-Day Volatility
+192.30%
Return
Best Daily Return
60 days
+89.74%
120 days
+89.74%
5 years
--
Worst Daily Return
60 days
-32.88%
120 days
-51.43%
5 years
--
Sharpe Ratio
60 days
+0.68
120 days
-0.23
5 years
--
Risk Assessment
Maximum Drawdown
240 days
+93.24%
3 years
+95.65%
5 years
--
Return-to-Drawdown Ratio
240 days
-0.85
3 years
-0.04
5 years
--
Skewness
240 days
+2.20
3 years
+1.65
5 years
--
Volatility
Realised Volatility
240 days
+192.30%
5 years
--
Standardised True Range
240 days
+34.82%
5 years
--
Downside Risk-Adjusted Return
120 days
-38.75%
240 days
-38.75%
Maximum Daily Upside Volatility
60 days
+520.46%
Maximum Daily Downside Volatility
60 days
+123.75%
Liquidity
Average Turnover Rate
60 days
+0.56%
120 days
+1.00%
5 years
--
Turnover Deviation
20 days
+142.95%
60 days
+28.41%
120 days
+127.64%
Peer Comparison
Healthcare Equipment & Supplies
EUDA Health Holdings Ltd
EUDA
5.68 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
LNTH
8.73 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Anika Therapeutics Inc
ANIK
8.56 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LIVN
8.42 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
TMO
8.35 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Bruker Corp
BRKR
8.26 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
